Epigral (EPIGRAL) | Stock Overview & Key Data
Epigral Performance Comparison
Stock Range
Today's Range
Low: ₹1,731.00
High: ₹1,759.80
on September 23, 2025
52 Week Range
Low: ₹1,502.35
High: ₹2,406.75
on January 13, 2025
on October 3, 2024
All-Time High: ₹2,406.75 on September 30, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR74.9B
EPS
101.24
P/E Ratio (TTM)
17.14
Forward P/E
18.00
P/B Ratio
3.93
PEG Ratio
0.21
Div. Yield
0.64%
ROE
18.78%
Beta
-0.145
Debt to Equity
31.11
Financial Highlights
Profitability
Gross Margin
47.40%
Operating Margin
20.09%
Profit Margin
17.26%
Returns and Earnings
Return on Assets (TTM)
11.35%
Return on Equity (TTM)
18.78%
EBITDA
INR7.0B
Net Income (TTM)
INR4.3B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR580.76
Quarterly Revenue Growth (YoY)
-6.90%
Quarterly Earnings Growth (YoY)
87.10%
Dividend Information
Last 12-Month Dividend
₹11.00
Current Dividend Yield
0.64%
3-Year Average Dividend Yield
0.22%
3-Year Average Annual Dividend
₹3.67
3-Year Total Dividends
₹11.00
Ex-Dividend Date
June 20, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Epigral EPIGRAL | 74.90B Mid-cap | -2.13% | -5.37% | -0.17% | -12.38% | -7.42% | -22.26% | 72.84% | 72.84% |
| Tata Chemicals TATACHEM | 256.19B Large-cap | -2.31% | 1.02% | 6.01% | 12.58% | -7.56% | -10.05% | -13.11% | 218.27% |
| Navin Fluorine NAVINFLUOR | 240.49B Large-cap | -3.56% | -6.15% | 1.11% | 11.79% | 43.03% | 36.81% | 4.47% | 119.82% |
| Deepak Fertilisers DEEPAKFERT | 191.87B Mid-cap | 6.55% | 1.14% | -1.89% | 34.91% | 24.63% | 42.50% | 72.79% | 885.78% |
| Archean Chemical ACI | 87.41B Mid-cap | -0.92% | 3.25% | 14.17% | 30.14% | 5.72% | 1.54% | 32.48% | 32.48% |
| Gujarat Narmada GNFC | 74.08B Mid-cap | -0.84% | -5.02% | -4.71% | 1.03% | -11.01% | -25.41% | -21.51% | 136.73% |
Ownership & Short Interest
Insider Ownership
69.01%
Institutional Ownership
5.20%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
22K
Average 90-Day Volume
24K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is EPIGRAL's 52-week high and low?
- In the last 52 weeks, Epigral reached a high of ₹2,406.75 (on October 3, 2024) and a low of ₹1,502.35 (on January 13, 2025).
- What is the market cap and P/E ratio for EPIGRAL?
- Curious about Epigral's size and valuation? Its market capitalization stands at 74.90B. When it comes to valuation, the P/E ratio (trailing twelve months) is 17.14, and the forward P/E (looking ahead) is 18.00.
- Does EPIGRAL pay dividends? If so, what's the yield?
- Yes, Epigral is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.64%, and the company has paid an average of ₹3.67 per share annually over the past 3 years.
- Who are Epigral's main competitors or similar companies to consider before investing?
When looking at Epigral, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Tata Chemicals
TATACHEM256.19B Basic Materials Chemicals -10.05% -13.11% Navin Fluorine
NAVINFLUOR240.49B Basic Materials Chemicals 36.81% 4.47% Deepak Fertilisers
DEEPAKFERT191.87B Basic Materials Chemicals 42.50% 72.79% Archean Chemical
ACI87.41B Basic Materials Chemicals 1.54% 32.48% Gujarat Narmada
GNFC74.08B Basic Materials Chemicals -25.41% -21.51% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Epigral Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Epigral's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 18.78%, the Debt to Equity ratio from the most recent quarter is 31.11, and its Gross Profit Margin stands at 47.40%.
- What is the recent revenue and earnings growth for EPIGRAL?
- Looking at Epigral's growth, its revenue over the trailing twelve months (TTM) was INR25B. Compared to the same quarter last year (YoY), quarterly revenue grew by -6.90%, and quarterly earnings saw a YoY growth of 87.10%.
- How much of EPIGRAL stock is held by insiders and institutions?
- Wondering who owns Epigral stock? Company insiders (like executives and directors) hold about 69.01% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 5.20%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.